![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 39, 35980-35989, September 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,

From the Phosphodiesterase 4D (PDE4D), part of the complex
cAMP-specific PDE4 family, plays a pivotal role in the
regulation of airway smooth muscle relaxation by catalyzing the
hydolysis of cAMP. Its gene on chromosome 5q12 encodes 5 splice
variants, which show tissue-dependent expression and
regulation. The genomic arrangement of PDE4D was determined using
in silico methods, and a putative promoter of one of the
protein kinase A-activated, long isoforms, PDE4D5 was identified.
Promoter-luciferase constructs, transiently transfected into a
Division of Therapeutics and Institute of
Cell Signalling, University Hospital, Nottingham NG7 2UH, United
Kingdom, the ¶ Department of Respiratory Medicine, Floor 6, Gartnavel General Hospital, Great Western Road, Glasgow, G12, the
** Molecular Pharmacology Group, Division of Biochemistry and
Molecular Biology, Davidson Building, Institute of Biomedical and
Life Sciences, University of Glasgow, Glasgow G12 8QQ, United
Kingdom, and the
Novartis Horsham Research Centre, Wimblehurst
Road, Horsham RH12 5AB, United Kingdom
2 adrenoreceptor-expressing CHO-K1 cell line, were used
to demonstrate that the PDE4D5 promoter up-regulated reporter gene
expression in response to increased cell cAMP. Site-directed mutagenesis of the cAMP-response element (CRE) at position
201 identified this as the principal component of the mechanism underlying this cAMP responsiveness. In the second part of this study,
cAMP-dependent induction of PDE4D5 transcript in primary
cultured human airway smooth muscle cells (hASMs) was demonstrated
using both qualitative reverse-transcriptase PCR and quantitative
real-time PCR. Isolated PDE4D5 isoenzyme activity, measured after
selective immunoprecipitation from hASMs, confirmed that this increase
in expression led to an up-regulation of functional activity. We
present evidence for cAMP-driven PDE4D5 up-regulation in hASMs and
suggest a CRE-containing, isoform-specific promoter as the primary mechanism.

To whom correspondence should be addressed: Division of
Therapeutics, C Floor South Block, University Hospital, Nottingham NG7
2UH, United Kingdom. Tel.: 44-115-9709905; Fax: 44-115-9422232; E-mail:
ian.hall@nottingham.ac.uk.
This article has been cited by other articles:
![]() |
C. K. Billington, I. R. Le Jeune, K. W. Young, and I. P. Hall A Major Functional Role for Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Houslay, G. S. Baillie, and D. H. Maurice cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling Circ. Res., April 13, 2007; 100(7): 950 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Omori and J. Kotera Overview of PDEs and Their Regulation Circ. Res., February 16, 2007; 100(3): 309 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, J. R. Tang, Y. H. Choi, M. Napolitano, S. Hockman, M. Taira, E. Degerman, and V. C. Manganiello Importance of cAMP-response Element-binding Protein in Regulation of Expression of the Murine Cyclic Nucleotide Phosphodiesterase 3B (Pde3b) Gene in Differentiating 3T3-L1 Preadipocytes J. Biol. Chem., July 28, 2006; 281(30): 21096 - 21113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lynch, G. S. Baillie, A. Mohamed, X. Li, C. Maisonneuve, E. Klussmann, G. van Heeke, and M. D. Houslay RNA Silencing Identifies PDE4D5 as the Functionally Relevant cAMP Phosphodiesterase Interacting with {beta}Arrestin to Control the Protein Kinase A/AKAP79-mediated Switching of the {beta}2-Adrenergic Receptor to Activation of ERK in HEK293B2 Cells J. Biol. Chem., September 30, 2005; 280(39): 33178 - 33189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Tilley and D. H. Maurice Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated Function Mol. Pharmacol., September 1, 2005; 68(3): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Houslay The Long and Short of Vascular Smooth Muscle Phosphodiesterase-4 As a Putative Therapeutic Target Mol. Pharmacol., September 1, 2005; 68(3): 563 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wallace, L. A. Johnston, E. Huston, D. MacMaster, T. M. Houslay, Y.-F. Cheung, L. Campbell, J. E. Millen, R. A. Smith, I. Gall, et al. Identification and Characterization of PDE4A11, a Novel, Widely Expressed Long Isoform Encoded by the Human PDE4A cAMP Phosphodiesterase Gene Mol. Pharmacol., June 1, 2005; 67(6): 1920 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Barber, G. S. Baillie, R. Bergmann, M. C. Shepherd, R. Sepper, M. D. Houslay, and G. V. Heeke Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L332 - L343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Fenech, C. K. Billington, C. Swan, S. Richards, T. Hunter, M. J. Ebejer, A. E. Felice, R. Ellul-Micallef, and I. P. Hall Novel Polymorphisms Influencing Transcription of the Human CHRM2 Gene in Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 678 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Baker, I. P. Hall, and S. J. Hill Temporal Characteristics of cAMP Response Element-Mediated Gene Transcription: Requirement for Sustained cAMP Production Mol. Pharmacol., April 1, 2004; 65(4): 986 - 998. [Abstract] [Full Text] |
||||
![]() |
R. Draheim, U. Egerland, and C. Rundfeldt Anti-Inflammatory Potential of the Selective Phosphodiesterase 4 Inhibitor N-(3,5-Dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), in Human Cell Preparations J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 555 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Conti, W. Richter, C. Mehats, G. Livera, J.-Y. Park, and C. Jin Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling J. Biol. Chem., February 14, 2003; 278(8): 5493 - 5496. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |